JW Therapeutics anuncia início do estudo clínico do JWATM204 em pacientes com carcinoma hepatocelular avançado ...Middle East

XANGAI, 4 de julho de 2022 /PRNewswire/ -- A JW Therapeutics (HKEX: 2126), uma empresa de biotecnologia independente e inovadora que se concentra no desenvolvimento, fabricação e comercialização de produtos de imunoterapia celular, anunciou o início do estudo clínico de Fase I do JWATM204...

Hence then, the article about jw therapeutics anuncia inicio do estudo clinico do jwatm204 em pacientes com carcinoma hepatocelular avancado was published today ( Monday 04/07/2022 - 02:40 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( JW Therapeutics anuncia início do estudo clínico do JWATM204 em pacientes com carcinoma hepatocelular avançado )

Also on site :

• I-70 closed in Glenwood Canyon for safety concerns, police activity
• Russian cat becomes world champion 2025
• What we know about the alleged arson at Mississippi’s largest and oldest synagogue